Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
November 20 2007 - 11:00AM
PR Newswire (US)
HD*PET, Symbia(R) TruePoint(TM) SPECT-CT and Symbia E to be
Featured HOFFMAN ESTATES, Ill., Nov. 20 /PRNewswire-FirstCall/ --
From innovative new product solutions to clever additions to
existing technology, Siemens Medical Solutions
(http://www.usa.siemens.com/medical) is propelling the field of
molecular medicine to new heights. Working across clinical areas,
including oncology, neurology and cardiology, Siemens will be
presenting its latest molecular imaging technologies at the 93rd
Scientific Assembly and Annual Meeting of the Radiological Society
of North America (RSNA) from Nov. 25 to 30 in Chicago (Booth #7713,
Hall B). (Logo:
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ) "We are
committed to introducing technologies that not only open up new
doors in how disease and conditions are imaged, but also to
refining those images to provide the clearest and most uniform
presentation for those interpreting them," said Michael Reitermann,
president, Molecular Imaging Division, Siemens Medical Solutions.
"With an innovation like HD*PET, Siemens Medical Solutions is
giving physicians increased image clarity that we couple with our
TrueV technology for one of the largest field of the views in the
industry. The end result is a solution that improves workflow and
diagnostic confidence." Siemens is redefining the quality of
molecular imaging with the introduction of high-definition positron
emission tomography. HD*PET is the world's first and only
high-definition PET technology to offer consistently sharper and
clearly defined images across the entire field of view. The clarity
achieved by HD*PET is the result of a unique and proprietary
technology that optimizes the elements of image uniformity,
resolution and contrast - that together change the whole picture.
Historically with PET imaging, intrinsic image quality has been
known to degrade with increasing distance from the center of the
detector. HD*PET eliminates this effect, thus providing increased
diagnostic confidence to more accurately resolve peripheral
lesions. This, in turn, could potentially improve diagnosis and
staging of disease and hence clinical outcomes. The improved 2-mm
resolution enables physicians to clearly visualize the smallest of
lesions from the center to the edges of the field of view. Siemens
Hybrid Imaging Solutions Siemens has also newly redesigned the
mobile Biograph(TM) 6 TruePoint(TM) PET*CT system. The redesigned
system incorporates hardware improvements such as a shorter gantry
to reclaim critical space in the scan room, a special cantilevered
patient handling system with automatic lock-down and a completely
integrated closed-loop cooling system with no external chilling
requirement. The new mobile systems also boast significant workflow
improvements to facilitate remote operation and support for
multiple site connectivity. With the introduction of another hybrid
imaging technology, the TruePoint SPECT*CT, clinicians can perform
three different studies - single photon emission computed
tomography (SPECT), diagnostic multislice-CT, and SPECT*CT - on one
compact, integrated system. Siemens has recently introduced the
Symbia(R) T16 TruePoint SPECT*CT configuration, which combines the
power of SPECT imaging with the precision of a 16-slice CT. Siemens
Medical Solutions Molecular Imaging has seen worldwide demand for
these solutions growing and these systems have a range of
applications in oncology and cardiology. With the 16-slice
configuration, users benefit from better temporal resolution in
cardiology studies as well as improved image resolution to boost
diagnostic confidence. Symbia E The Symbia E is the newest addition
to the Symbia family of SPECT and SPECT*CT imaging systems. It
provides users with a high-quality SPECT imager that can lead to
improved clinical confidence, reliability and versatility. "Siemens
continually evaluates its product offerings to ensure that we help
our global customers deliver the best outcomes while addressing
their financial concerns," said Reitermann. "The Symbia E is primed
to be the newest general imaging SPECT and cardiac SPECT workhorse
for cost-conscious customers who need a serious return on their
investment." Based on state-of-the-art Symbia SPECT*CT technology
and award-winning design, Symbia E leverages the strength of the
industry's leading gamma camera, the e.cam. There are more than
4,000 e.cams installed in more than 120 countries, proving that the
system is an industry icon. Siemens has improved upon the e.cam
system structure and the Symbia E boasts features that will allow
healthcare providers to work with increased confidence, which will
lead to an accelerated workflow. The system is also versatile and
it can be upgraded as a facility's workload grows. Preclinical
Imaging and Radiopharmaceutical Preparation Siemens' preclinical
multimodality imaging solutions offer a versatile and upgradeable
platform as well as a comprehensive suite of analysis applications.
Siemens' newest preclinical solution, Inveon(TM), is a modular
concept that offers complete flexibility, enabling PET, SPECT, and
CT data acquisition, and provides the industry's highest PET
resolution and sensitivity. Inveon's suite of research tools can
help facilitate basic research, as well as the drug development
process, empowering researchers to identify specific biological
processes, monitor the efficacy of compounds, and measure the
effects of disease progression over time. Siemens also offers
products for the preparation of radiopharmaceuticals. The
Explora(R) family of radiochemistry modules offers a comprehensive
line of products for efficient preparation of radiolabeled PET
compounds. On a larger scale, the Eclipse family of PET cyclotrons
is Siemens' solution for radioisotope production of
18-fluoride-based radiotracers, as well as production N-13, 0-15
and C-11 isotopes. Tying it all together, Siemens Molecular Imaging
(MI) University, a fundamental part of MI LifeNet - Siemens'
customer care initiative - provides a substantive training resource
for Siemens' customers. Today's molecular imaging professionals
require continuous education, training and the ability to share
results. Designed to be used by the interpreting physician,
referring physician and technologist, MI University demonstrates
the benefits of hybrid PET*CT and SPECT*CT systems, including when
and how hybrid imaging influences patient management, through
access to valuable clinical data and detailed case studies; video
lectures; product information; and a tool for information exchange
among peers. Availability of FLT to NCI Research Sites Siemens also
recently announced that the National Cancer Institute has filed a
cross-reference letter to a Type II Drug Master File that Siemens
submitted to the U.S. Food and Drug Administration for its
investigational 3'Deoxy-3'[18F] Fluorothymidine (F-18 FLT) imaging
biomarker. The cross reference allows F-18 FLT to be produced and
used by any principle investigator in an NCI multi-center clinical
trial. In addition, the imaging biomarker will be available to
independent investigators if they receive NCI approval. F-18 FLT is
produced by PETNET Solutions or Molecular Imaging Biomarker
Research, both subsidiary companies of Siemens Medical Solutions,
Molecular Imaging. The imaging biomarker has been used in studies
monitoring the proliferative activity of cancer cells and it is
currently being used in Phase-I clinical trials at several research
sites. About Siemens Medical Solutions Siemens Medical Solutions is
one of the world's largest suppliers to the healthcare industry.
The company is a renowned medical solutions provider with core
competence and innovative strength in diagnostic and therapeutic
technologies as well as in knowledge engineering, including
information technology and system integration. With its laboratory
diagnostics acquisitions, Siemens Medical Solutions will be the
first fully integrated diagnostics company, bringing together
imaging and lab diagnostics, therapy, and healthcare information
technology solutions, supplemented by consulting and support
services. The company delivers solutions across the entire
continuum of care - from prevention and early detection, to
diagnosis, therapy and care. Siemens Medical Solutions employs more
than 48,000 people worldwide and operates in 130 countries.
According to U.S. GAAP, in the fiscal year 2007 (Sept. 30), Siemens
Medical Solutions reported sales of Euro 9.85 billion, orders of
Euro 10.27 billion, and group profit of Euro 1.32 billion
(preliminary figures, unaudited). Further information can be found
by visiting http://www.siemens.com/medical.
http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO
http://photoarchive.ap.org/ DATASOURCE: Siemens Medical Solutions
CONTACT: Mark Palacio, Corporate Communications of Siemens AG,
+1-610-448-1477, Web site: http://www.siemens.com/medical
http://rsna2007.rsna.org/rsna2007/V2007/index.cvn
Copyright